Taysha Gene Therapies Inc (TSHA)

Taysha Gene Therapies Inc

TSHA

Datum	Typ	Insider	Position	Ø-Preis	Volumen
10.7.2026	Verkauf	Nagendran, Sukumar	President and Head of R&D	6,2 $	1.248.000 $
10.4.2026	Verkauf	Nagendran, Sukumar	President and Head of R&D	4,5 $	892.000 $
4.2.2026	Verkauf	Alam, Kamran	CHIEF FINANCIAL OFFICER	4,5 $	7.481 $
26.1.2026	Verkauf	Nolan, Sean P.	Chief Executive Officer	4,6 $	190.448 $
26.1.2026	Verkauf	Nagendran, Sukumar	President and Head of R&D	4,6 $	124.092 $
26.1.2026	Verkauf	Alam, Kamran	CHIEF FINANCIAL OFFICER	4,6 $	109.944 $
23.1.2026	Verkauf	Nolan, Sean P.	Chief Executive Officer	4,8 $	649.748 $
23.1.2026	Verkauf	Nagendran, Sukumar	President and Head of R&D	4,8 $	423.377 $
23.1.2026	Verkauf	Alam, Kamran	CHIEF FINANCIAL OFFICER	4,8 $	375.098 $
12.1.2026	Verkauf	Nagendran, Sukumar	President and Head of R&D	4,7 $	942.000 $
1.12.2025	Verkauf	Nagendran, Sukumar	President and Head of R&D	4,5 $	1.172.812 $
28.11.2025	Verkauf	Nagendran, Sukumar	President and Head of R&D	4,8 $	523.094 $
10.9.2025	Verkauf	Nagendran, Sukumar	President and Head of R&D	3,2 $	646.000 $
21.8.2025	Verkauf	Alam, Kamran	CHIEF FINANCIAL OFFICER	2,8 $	155.299 $
21.8.2025	Verkauf	Nagendran, Sukumar	President and Head of R&D	2,8 $	162.604 $
30.5.2025	Kauf	Manning, Paul B.	Zehn-Prozent-Eigentümer	2,8 $	2.062.500 $